Bausch Health
BHC
#3957
Rank
C$4.41 B
Marketcap
C$11.79
Share price
-3.97%
Change (1 day)
38.63%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): C-$3.09

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is C-$3.26. In 2025 the company made an earnings per share (EPS) of C$0.60 an increase over its 2024 EPS that were of C-$0.17.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.09-613.09%
2025C$0.60-450%
2024C-$0.17-92.59%
2023C-$2.32160.89%
2022C-$0.89-76.64%
2021C-$3.8168.45%
2020C-$2.26-68.91%
2019C-$7.28-57.11%
2018C-$16.97-272.22%
2017C$9.85-199.29%
2016C-$9.92798.7%
2015C-$1.10-128.31%
2014C$3.90-204.62%
2013C-$3.73602.7%
2012C-$0.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.27-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.36-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA